Akums Drugs and Pharmaceutical (AKUMS) — Net Asset Quality Index
Akums Drugs and Pharmaceutical (AKUMS) has a Net Asset Quality Index of 61.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs54.47 Billion minus total liabilities of Rs21.16 Billion yields net assets of Rs33.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Akums Drugs and Pharmaceutical total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Akums Drugs and Pharmaceutical Net Asset Quality Index Over Time (2022–2026)
This chart shows how Akums Drugs and Pharmaceutical's Net Asset Quality Index has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the index stands at 61.2%, representing net assets of Rs33.31 Billion against total assets of Rs54.47 Billion INR. For live market cap and overall valuation, see Akums Drugs and Pharmaceutical stock valuation.
Annual Net Asset Quality Index for Akums Drugs and Pharmaceutical (2022–2026)
The table below presents the year-by-year Net Asset Quality Index for Akums Drugs and Pharmaceutical from 2022 to 2026, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See net assets of Akums Drugs and Pharmaceutical for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 61.2% | Rs33.31 Billion | Rs54.47 Billion | Rs21.16 Billion | ▼ -13.3 pp |
| 2025 | 74.5% | Rs30.64 Billion | Rs41.13 Billion | Rs10.50 Billion | ▲ +54.0 pp |
| 2024 | 20.5% | Rs7.20 Billion | Rs35.16 Billion | Rs27.96 Billion | ▼ -1.7 pp |
| 2023 | 22.1% | Rs7.23 Billion | Rs32.67 Billion | Rs25.43 Billion | ▲ +1.8 pp |
| 2022 | 20.4% | Rs6.25 Billion | Rs30.69 Billion | Rs24.44 Billion | — |